Search Results - "Venugopalan, Veena"

Regulatory oversight and safety of probiotic use by Venugopalan, Veena, Shriner, Kimberly A, Wong-Beringer, Annie

“…Depending on intended use of a probiotic (drug vs. dietary supplement), regulatory requirements differ greatly. For dietary supplements, premarketing…”
Get full text

A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe Pneumonia by Maranchick, Nicole F, Trillo-Alvarez, Cesar, Kariyawasam, Vidhu, Venugopalan, Veena, Kwara, Awewura, Rand, Kenneth, Peloquin, Charles A, Alshaer, Mohammad H

“…Antimicrobial resistance is a growing health concern worldwide. The objective of this study was to evaluate the effect of beta-lactam infusion on the emergence…”
Get full text

Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies by Lodl, Emma F, Alshaer, Mohammad H, Adams, C. Brooke, Richards, Ashley, Peloquin, Charles, Venugopalan, Veena

“…Introduction Cefepime is a fourth-generation cephalosporin and is a workhorse for the empiric treatment of febrile neutropenia (FN). Beta-lactam therapeutic…”
Get full text

Impact of an antimicrobial stewardship initiative on time to administration of empirical antibiotic therapy in hospitalized patients with bacteremia by Bias, Tiffany E, Vincent, William R, Trustman, Nathan, Berkowitz, Leonard B, Venugopalan, Veena

“…PURPOSE.The impact of an antimicrobial stewardship initiative on time to first antibiotic dose and clinical outcomes in bacteremic patients was evaluated…”
Get full text

The OPAT opportunity for beta-lactam individualization by Childs-Kean, Lindsey M, Rivera, Christina G, Venugopalan, Veena, Johnson, Madelyn J, Barreto, Erin F

“…Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral…”
Get full text

Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infections (REDUCE-BSI) by Vu, Catherine H, Venugopalan, Veena, Santevecchi, Barbara A, Voils, Stacy A, Ramphal, Reuben, Cherabuddi, Kartikeya, DeSear, Kathryn

“…To re-examine the use of noncarbapenems (NCBPs), specifically piperacillin-tazobactam (PTZ) and cefepime (FEP), for extended-spectrum beta-lactamase-producing…”
Get full text

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion by Venugopalan, Veena, Manigaba, Kayihura, Borgert, Samuel J, Cope, Jessica, Peloquin, Charles A, Klinker, Kenneth P

“…Background: The antibiotic armamentarium used to combat multi-drug resistant organisms (MDROs) include carbapenems. Continuous infusion (CI) dosing is…”
Get full text

Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients by Al-Shaer, Mohammad H, Rubido, Eric, Cherabuddi, Kartikeya, Venugopalan, Veena, Klinker, Kenneth, Peloquin, Charles

“…In the ICU, early and appropriate antimicrobial therapy is important to lower infection-related mortality. Assess whether achieving early β-lactam free…”
Get full text

Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections by Nys, Cara, Cherabuddi, Kartik, Venugopalan, Veena, Klinker, Kenneth P

“…is an opportunistic pathogen observed in nosocomial infections. Due to biofilm production and resistance to numerous antimicrobials, eradication is difficult…”
Get full text

Delayed interval delivery and survivability of the second twin with and without emergency cerclage in dichorionic diamniotic pregnancy. A systematic review by Maducolil, Mariam Kunjachen, Loughman, Emily, Mohan, Manoj, Venugopalan, Veena, Lindow, Stephen W.

“…•Systematic review analyzing role of cervical cerclage to improve perinatal outcome of second twin in Dichorionic Diamniotic pregnancies.•Cervical cerclage…”
Get full text

An Update on Existing and Emerging Data for Meropenem-Vaborbactam by Shoulders, Bethany R., Casapao, Anthony M., Venugopalan, Veena

“…The search for new agents to treat multidrug-resistant gram-negative bacterial infections has been ongoing. Specifically, carbapenem-resistant…”
Get full text

Letter to the editor (infection after penetrating brain injury) by Voils, Stacy A., Shoulders, Bethany R., Venugopalan, Veena

Get full text

Letter to the editor (infection after penetrating brain injury) by Voils, Stacy A., Shoulders, Bethany R., Venugopalan, Veena

Get full text

Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study by Garg, Mahek, Venugopalan, Veena, Vouri, Scott M, Diaby, Vakaramoko, Iovine, Nicole M, Park, Haesuk

“…To investigate risk of aortic aneurysm or dissection in patients using oral fluoroquinolones compared to those using macrolides in real-world clinical practice…”
Get full text

Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV by Harrison, Iris, DeSear, Kathryn, Santevecchi, Barbara A, Venugopalan, Veena, Cherabuddi, Kartikeya, Iovine, Nicole, Radhakrishnan, Nila

“…A man with advanced HIV presented with verrucous plaques 2-3 months after initial mpox infection. He received two courses of tecovirimat without resolution of…”
Get more information

Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool by Hashem, Nehal Gamal, Hidayat, Levita, Berkowitz, Leonard, Venugopalan, Veena

“…Skin and soft-tissue infections (SSTIs) encompass a diverse range of infections of varying severity. The Clinical Resource Efficiency Support Team (CREST)…”
Get full text

Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patients by Zheng, Lily, Alshaer, Mohammad H., Peloquin, Charles, Venugopalan, Veena, Alnuaimat, Hassan M., Converse, Maureen

“…The impact of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics/dynamics (PK/PD) of beta-lactam antibiotics have not been well studied in…”
Get full text

952: BETA-LACTAM EXPOSURE IN ICU PATIENTS AND ASSOCIATED OUTCOMES: A PROSPECTIVE OBSERVATIONAL STUDY by Alshaer, Mohammad, Maguigan, Kelly, Murray, Melissa, Venugopalan, Veena, Ashton, Jennifer, Shoulders, Bethany, DeSear, Kathryn, Santevecchi, Barbara, Cherabuddi, Kartik, Peloquin, Charles

Get full text

Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018 by Garg, Mahek, Venugopalan, Veena, Vouri, Scott M., Diaby, Vakaramoko, Iovine, Nicole M., Wilson, Debbie L., Park, Haesuk

“…Background One of the goals established by the United States National Action Plan to Combat Antibiotic‐Resistant Bacteria is to reduce inappropriate outpatient…”
Get full text

Ampicillin-Sulbactam for Carbapenem-Susceptible Acinetobacter baumannii Pneumonia: A Case for High-Dose, Continuous Infusion Dosing Strategy in the Trauma ICU by Shoulders, Bethany R, Santevecchi, Barbara A, Venugopalan, Veena, Alexander, Kaitlin M

“…: The optimal ampicillin-sulbactam dosing regimen for carbapenem-susceptible isolates in critically ill trauma patients has not been clearly defined. One…”
Get more information